TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
cancelled
Official procurement procedure

Enterprise Resource Planning (ERP) solution

Enterprise resource planning software development services
Enterprise resource planning software package
Office and computing machinery
+2 more
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Vaccines Manufacturing and Innovation Centre (UK) Limited: "Enterprise Resource Planning (ERP) solution". Published status: cancelled. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityVaccines Manufacturing and Innovation Centre (UK) LimitedScope & CategoriesNot publishedSubmission Window
cancelled
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Vaccines Manufacturing and Innovation Centre (UK) Limited
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Vaccines Manufacturing and Innovation Centre (UK) Limited. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
Not availableNo published reports
Bid counts are not published for this buyer
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 0 active published awards; 0 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published
Procurement categoryNot published
Statuscancelled
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published3 Sept 2021, 10:50 BST
Last source update3 Sept 2021, 10:50 BST
Recurring procurementNot published
ClassificationEnterprise resource planning software development services, Enterprise resource planning software package, Office and computing machinery, equipment and supplies except furniture and software packages, Software consultancy services
Delivery area
UK
OCIDocds-h6vhtk-029a4d
What is being bought
Enterprise Resource Planning (ERP) System potentially including Manufacturing, Materials Movement, Warehousing, Order Management, Quality Management, Engineering, Asset Management, Finance and Human Resources sub-systems. The system will be required to operate in a regulated pharmaceutical environment and must conform to GxP compliance requirements including EudraLex Volume 4, EudraLex Volume 4 Annex 11, and US FDA 21 CFR parts 11, 210 and 211. The solution is required to be a cloud-based 'Software as a Service' solution, to include Consultation, Project Management, Implementation, Hosting, Service Support and upgrades and must include robust Disaster Recovery Planning and Business Continuity provisions. The system and all data must be hosted in the UK. Please note that this procurement opportunity has been cancelled. The procedure has been discontinued at SQ stage due to changes in business requirements and priorities. VMIC is in the process of considering its future requirements and will take any decision on any future procurement once this process has completed.
What changed
From the official release history
  1. tender value changed
    3 Sept 2021, 10:50 BST
  2. Status changed to cancelled
    3 Sept 2021, 10:50 BST
  3. Official notice release published
    3 Sept 2021, 10:50 BST
  4. Submission deadline changed to published date
    3 Sept 2021, 10:50 BST
  5. Buyer information updated
    3 Sept 2021, 10:50 BST
  6. Published value updated to £7,000,000
    10 Mar 2021, 13:36 GMT
  7. Status changed to active
    10 Mar 2021, 13:36 GMT
  8. Official notice release published
    10 Mar 2021, 13:36 GMT
  9. Submission deadline changed to 9 Apr 2021, 17:00 BST
    10 Mar 2021, 13:36 GMT
  10. Buyer information updated
    10 Mar 2021, 13:36 GMT
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    The Vaccines Manufacturing and Innovation Centre (VMIC) is being established to promote, develop and accelerate the growth of the UK vaccine industry. This will be achieved through collaboration with the academic sector and subject matter experts which are rich in new vaccine technologies. VMIC provides expertise in process development and will provide manufacturing in the form of expert staff and a state-of-the-art manufacturing facility. VMIC will bridge the gap between research and expertise in development and manufacturing so that new vaccine products can enter clinical development. This is a value driver in terms of attracting funding for further development and partnering with the pharmaceutical industry for development to launch and manufacture vaccines. VMIC will also enhance UK preparedness and response capabilities for producing vaccines against emerging infectious diseases by allowing the UK government to use the facility and staff during an outbreak identified as a public health emergency of international concern. VMIC is a partner in the project to manufacture the Oxford Covid-19 vaccine. The programme has now reached the phase in which an ERP System needs to be procured and its deployment built into the plan. The compliance environment within which the organisation operates is governed by the following regulations which impose rigorous requirements on the organisation: 1) Eudralex Volume 4: Good Manufacturing Practice 2) Eudralex Volume 4 Good Manufacturing Practice: Annex 11 Computerised Systems 3) US FDA 21 CFR Part 11: Electronic Records & Electronic Signatures 4) US FDA 21 CFR Part 210: Current Good Manufacturing Practice in Manufacturing, Processing, Packing, or Holding of Drugs 5) US FDA 21 CFR Part 211: Current Good Manufacturing Practice for Finished Pharmaceuticals Given the prevailing circumstances VMIC must make every effort to bring online its manufacturing and support services at the earliest opportunity. To meet this goal the implementation of an ERP system is considered an urgent requirement. VMIC recognises that the service provider will be required to speedily provide robust solutions to its specific industry needs and anticipates a fully-managed configured off-the-shelf solution delivered with extensive support services based on industry knowledge and expertise, best in class project management and a low risk rapid implementation. The expectation of VMIC is that that the solution can be implemented using a staged modular approach. Initial licensing estimates will be based on 30 concurrent and 60 named user licenses. The form of contract will be based on the UK Government Mid-Tier model. The anticipated Term will be three years with an option to extend twice by 2 years on each occasion. Please note that this procurement opportunity has been cancelled. The procedure has been discontinued at SQ stage due to changes in business requirements and priorities. VMIC is in the process of considering its future requirements and will take any decision on any future procurement once this process has completed.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    3 Sept 2021, 10:50 BST
  2. Award unsuccessful
    Not published · Not published
Commercial outcome and competition
Awards
Awarded supplier not published
Not published · Not published · unsuccessful
ContractsNo contract published
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

Vaccines Manufacturing and Innovation Centre (UK) Limited

Contracting authority GB-FTS-27279
View buyer profile
  • Vaccines Manufacturing and Innovation Centre (UK) Limited
    buyer

    Building B587 Harwell Campus, Didcot, UK, OX11 0RH
  • Vaccines Manufacturing & Innovation Centre (UK) Ltd
    reviewBody

Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published